Indication
Polyneuropathy
3 clinical trials
4 products
Product
RiliprubartClinical trial
A Phase 3, Doubleblind, Placebocontrolled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating PolyneuropathyStatus: Recruiting, Estimated PCD: 2026-02-03
Product
PlaceboProduct
Alpha-Lipoic AcidClinical trial
Tafamidis 61mg, Resultados en Amiloidosis ATTR Con afectación neurológica y Multisistémica - TRAMAStatus: Completed, Estimated PCD: 2022-11-15
Product
TafamidisClinical trial
A Multicenter, Interventional, Two-arm, Parallel-group, Randomized, Double-blinded, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy of Alpha-Lipoic Acid in the Treatment of Symptomatic Diabetic Polyneuropathy in EgyptStatus: Recruiting, Estimated PCD: 2024-04-01